Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahd Hamidi

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Pharmaceutical Sciences|October 9, 2020
Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral DeliveryPrashant Kumar, Swathi R Pullagurla, Ashaben Patel, et al.
Vaccine|March 4, 2025
Sabin inactivated polio vaccine upstream process development using fixed-bed bioreactor technologyAhd Hamidi, Marieke Willemsen, Thomas Robert, et al.
Human Vaccines & Immunotherapeutics|April 16, 2021
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countriesPrashant Kumar, Ravi S Shukla, Ashaben Patel, et al.
Vaccine|March 21, 2021
Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccineAhd Hamidi, Femke Hoeksema, Pim Velthof, et al.
Vaccine|June 10, 2011
Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPVWilfried A M Bakker, Yvonne E Thomassen, Aart G van't Oever, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Pharmaceutical Sciences|October 9, 2020
Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral DeliveryPrashant Kumar, Swathi R Pullagurla, Ashaben Patel, et al.
Vaccine|March 4, 2025
Sabin inactivated polio vaccine upstream process development using fixed-bed bioreactor technologyAhd Hamidi, Marieke Willemsen, Thomas Robert, et al.
Human Vaccines & Immunotherapeutics|April 16, 2021
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countriesPrashant Kumar, Ravi S Shukla, Ashaben Patel, et al.
Vaccine|March 21, 2021
Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccineAhd Hamidi, Femke Hoeksema, Pim Velthof, et al.
Vaccine|June 10, 2011
Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPVWilfried A M Bakker, Yvonne E Thomassen, Aart G van't Oever, et al.
Pageof 2